Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib

Robert Galvin, Adrienne L. Watson, David A. Largaespada, Nancy Ratner, Sara Osum, Christopher L. Moertel

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib'. Together they form a unique fingerprint.

Medicine & Life Sciences